News|Articles|November 21, 2026

Skin Findings May Reveal Hidden Gastrointestinal Disease

NP/PA Connect
Listen
0:00 / 0:00

Key Takeaways

  • Dermatitis herpetiformis should prompt celiac evaluation with tTG-IgA and total IgA, recognizing false negatives with IgA deficiency or gluten avoidance; HLA-DQ2/DQ8 negativity effectively excludes celiac disease.
  • Persistent pruritus can be an early cholestasis signal, while spider angiomas and palmar erythema support cirrhosis consideration; hepatitis C screening (18–79 years) enables curative antiviral linkage to care.
SHOW MORE

DermNexus 2026 experts highlighted skin manifestations of GI and systemic diseases, emphasizing early diagnosis, screening, and coordinated care.

Skin findings may provide important clues to underlying gastrointestinal (GI), hepatic, and systemic inflammatory diseases, sometimes appearing before patients receive a formal diagnosis. Recognizing these manifestations can help dermatology clinicians identify patients who require additional evaluation, targeted laboratory testing, or multidisciplinary care.

During "GI Connection Red Flags in the Exam Room: Systemic Clues Not to Miss," the second educational session of Day 2 at DermNexus 2026: The Inflammatory Disease and Innovations Congress for NP/PAs, held November 21 in Scottsdale, Arizona, Israel D. Andrews, MD, and Sarabdeep Mann, MD, examined the connections between dermatologic presentations and underlying systemic conditions.

The discussion addressed celiac disease, dermatitis herpetiformis, inflammatory bowel disease (IBD), liver disease, dermatomyositis, and inflammatory ulcerative conditions. Through clinical examples and practical diagnostic considerations, the presenters emphasized the importance of looking beyond visible skin findings to identify potential systemic disease.

Recognizing Celiac Disease Through Skin Manifestations

The session began with a discussion of celiac disease and dermatitis herpetiformis, an intensely pruritic cutaneous manifestation associated with gluten-sensitive enteropathy.

Faculty emphasized the importance of selecting appropriate diagnostic tests when celiac disease is suspected, particularly tissue transglutaminase immunoglobulin A (tTG-IgA) testing alongside total IgA measurement.

Although tTG-IgA is a sensitive screening test, IgA deficiency can produce false-negative results. Similarly, patients who have already initiated a gluten-free diet may have reduced antibody levels, potentially complicating diagnosis.

Genetic testing for human leukocyte antigen (HLA)-DQ2 and HLA-DQ8 was discussed as an additional tool in selected circumstances. Negative results for these markers make celiac disease highly unlikely, whereas positive results do not independently establish a diagnosis.

The presenters also addressed the distinction between celiac disease and nonceliac gluten sensitivity, emphasizing that patients may experience gluten-related symptoms without demonstrating the serologic or intestinal changes characteristic of celiac disease.

For patients with confirmed celiac disease, a strict gluten-free diet remains the primary treatment.

Faculty highlighted the importance of adherence, particularly because untreated or poorly controlled disease can contribute to nutritional deficiencies, persistent intestinal injury, and an increased risk of certain malignancies, including small-bowel lymphoma.

Dermatologic Clues to Liver Disease

The presenters also reviewed cutaneous manifestations associated with hepatic disease, including primary biliary cholangitis (PBC) and hepatitis C infection.

Pruritus was highlighted as an important symptom of cholestatic liver disease, sometimes occurring before more recognizable signs of advanced hepatic dysfunction.

Additional findings discussed included spider angiomas and palmar erythema, which may appear in patients with cirrhosis.

Faculty encouraged clinicians to consider underlying hepatic disease when patients present with persistent unexplained pruritus, particularly when accompanied by abnormal liver function tests or other systemic findings.

Hepatitis C was another focus of the discussion, with the presenters emphasizing the importance of recognizing opportunities for screening.

The session referenced recommendations for one-time hepatitis C screening in adults aged 18 to 79 years and the availability of highly effective antiviral therapies.

For dermatology clinicians, the discussion reinforced the importance of recognizing possible systemic causes of skin symptoms and coordinating further evaluation when indicated.

Identifying Inflammatory Bowel Disease Through Skin Findings

The relationship between IBD and dermatologic disease was another central theme.

Andrews and Mann reviewed several cutaneous manifestations associated with Crohn disease and ulcerative colitis, including pyoderma gangrenosum, erythema nodosum, and cutaneous Crohn disease.

The discussion emphasized the importance of asking about GI symptoms when evaluating unexplained inflammatory lesions, particularly bloody diarrhea, nocturnal bowel movements, abdominal cramping, and changes in bowel habits.

Oral ulcers, weight loss, and other systemic symptoms may provide additional clues.

Pyoderma gangrenosum was highlighted as an important consideration in patients presenting with rapidly progressive, painful ulcerations.

Faculty emphasized pathergy, a phenomenon in which minor trauma can trigger or worsen inflammatory lesions.

Clinicians were encouraged to ask whether minor cuts, insect bites, or previous procedures had resulted in unusually severe ulceration.

Because pyoderma gangrenosum can worsen following trauma, the presenters stressed the importance of recognizing the condition before pursuing potentially harmful interventions.

The discussion also addressed the characteristic appearance of some lesions, including undermined borders and surrounding violaceous discoloration.

Importantly, faculty emphasized that inflammatory lesions may appear differently across skin tones, with erythema presenting as brown, purple, or darker discoloration rather than bright red.

Erythema Nodosum and Cutaneous Crohn Disease

Erythema nodosum was discussed as another inflammatory condition that may indicate underlying systemic disease.

Typically presenting as tender subcutaneous nodules, often on the lower legs, erythema nodosum can occur in association with IBD, infections, medications, and other inflammatory conditions.

Faculty noted that recent streptococcal infection may be relevant, particularly in younger patients, and that additional testing should be guided by clinical history and examination findings.

The presenters also reviewed cutaneous Crohn disease, which can produce granulomatous skin lesions separate from the gastrointestinal tract.

Clinical manifestations may include inflammatory plaques, nodules, fissures, and ulcerations involving genital, perianal, or other cutaneous sites.

Biopsy findings may demonstrate noncaseating granulomas, although other infectious and inflammatory causes must be considered.

The discussion emphasized that these lesions may resemble more common dermatologic conditions, potentially delaying recognition of underlying systemic disease.

Examining Nailfolds and Muscle Symptoms for Systemic Clues

Beyond gastrointestinal disorders, the session highlighted the importance of recognizing dermatologic manifestations of systemic autoimmune disease.

Dermatomyositis was discussed as an example of a condition in which cutaneous findings may provide important diagnostic clues.

Faculty reviewed characteristic manifestations, including violaceous periorbital discoloration, shawl-sign erythema, cuticular abnormalities, and nailfold changes.

The presenters encouraged clinicians to assess muscle function through targeted questions about activities such as climbing stairs, washing hair, or brushing hair.

Nailfold examination was also emphasized as a useful component of the dermatologic assessment, particularly when patients present with persistent or atypical inflammatory findings.

The discussion reinforced the importance of considering systemic autoimmune disease when cutaneous findings do not fit a typical presentation or fail to respond to conventional treatment.

Considering Treatment Selection in Patients With GI Comorbidities

The session also addressed the implications of underlying gastrointestinal disease when selecting systemic dermatologic therapies.

Faculty discussed the relationship between cytokine inhibition and intestinal inflammation, particularly among patients with psoriasis and coexisting IBD.

Interleukin (IL)-17 inhibitors were identified as treatments requiring particular consideration in patients with IBD because of concerns about exacerbating intestinal inflammation.

In contrast, IL-23–targeted therapies were discussed as options with evidence supporting efficacy in both psoriasis and certain forms of IBD.

The presenters emphasized the importance of asking patients about bowel symptoms before and during treatment, particularly when medications may influence gastrointestinal inflammatory pathways.

Janus kinase (JAK) inhibitors were also discussed, including considerations related to acne and elevated liver enzyme levels.

Faculty highlighted the importance of appropriate laboratory monitoring and patient counseling when initiating systemic therapies.

The discussion underscored the value of selecting treatments according to the patient's complete medical history rather than focusing exclusively on cutaneous disease activity.

Translating Clinical Red Flags Into Earlier Diagnosis

Throughout the session, Andrews and Mann reinforced the importance of taking a targeted history when patients present with atypical, persistent, or treatment-resistant dermatologic findings.

Questions about bowel habits, abdominal symptoms, oral ulcers, muscle weakness, medication exposure, and previous inflammatory conditions may reveal important clues that would otherwise be overlooked.

The presenters also emphasized the importance of selecting diagnostic tests based on clinical suspicion and recognizing when referral to gastroenterology, rheumatology, or another specialty is warranted.

As the understanding of skin-systemic disease connections continues to evolve, dermatology clinicians play an important role in recognizing potential warning signs and facilitating timely evaluation.

Ultimately, the session demonstrated that dermatologic examination extends beyond identifying skin disease alone. Recognizing the systemic implications of cutaneous findings may help clinicians identify previously undiagnosed conditions, avoid treatment-related complications, and provide more comprehensive, individualized patient care.

References

  1. Guttman-Yassky E, Croft M, Geng B, et al. The role of OX40 ligand/OX40 axis signalling in atopic dermatitis. Br J Dermatol. 2024;191(4):488-496. doi:10.1093/bjd/ljae230.
  2. Metz M, Giménez-Arnau A, Hide M, et al. Remibrutinib in chronic spontaneous urticaria. N Engl J Med. 2025;392(10):984-994. doi:10.1056/NEJMoa2408792.
  3. Ingram JR, et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol. 2019;180(5):1009-1017. doi:10.1111/bjd.17537.

Related to this article

Journal Digest: November 16
Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.